PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 194 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,441,000 | +67.8% | 102,125 | +46.9% | 0.20% | +94.1% |
| Q1 2019 | $2,647,000 | -31.8% | 69,540 | -23.0% | 0.10% | -35.0% |
| Q4 2018 | $3,883,000 | -15.6% | 90,260 | -3.6% | 0.16% | +16.3% |
| Q3 2018 | $4,602,000 | +665.7% | 93,640 | +643.2% | 0.14% | +743.8% |
| Q2 2017 | $601,000 | +188.9% | 12,600 | +486.0% | 0.02% | +220.0% |
| Q3 2014 | $208,000 | -1.4% | 2,150 | -6.5% | 0.01% | -16.7% |
| Q2 2014 | $211,000 | -0.9% | 2,300 | -48.3% | 0.01% | -14.3% |
| Q3 2013 | $213,000 | – | 4,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |